Delivery Order SPE2DR25D1002-SPE2DR26FGM2T
- Not listed
- The Defense Logistics Agency awarded a $6,497.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Benlysta 200 mg/mL auto-injectors. The contract, which represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical, is scheduled for completion by December 10, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,330.68 for Benlysta 200 mg/ml auto-injectors, with an ultimate completion date of September 25, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded a $6,165.36 delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector medication, with an ultimate completion date of November 13, 2025. This is a firm fixed price, non-set-aside contract awarded on October 22, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $6,497.32 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injector on December 29, 2025. This non-set-aside, competitively awarded contract represents a firm fixed price delivery order with an ultimate completion date of January 21, 2026. The award is fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a $6,497.32 firm fixed price delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Benlysta 200 mg/mL auto-injectors. This non-set-aside, competitively awarded contract is scheduled for completion by December 31, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under the company's broader Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $3,082.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injectors, with an ultimate completion date of November 10, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order valued at $9,248.01 to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector on August 28, 2025, with completion expected by September 19, 2025. This firm fixed-price delivery order is unclassified as a set-aside contract and represents a competitive award to the pharmaceutical distributor. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency has awarded a delivery order valued at $3,082.67 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injector medication. This competitively awarded, firm fixed price contract has an ultimate completion date of September 23, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of...
- The Defense Logistics Agency awarded a $9,745.98 delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Benlysta 200 mg/ml auto-injector medication. This is a firm fixed-price delivery order with performance to be completed by January 8, 2026, at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract award represents a non-set-aside, competitively awarded transaction under the company's existing federal contract vehicle with the agency. This...
- The Defense Logistics Agency awarded a $6,165.34 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Benlysta 200 mg/mL auto-injector medication. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 9, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- SPE2DR25D1002Indefinite Delivery Contract
- SPE2DR25D1002-SPE2DR26FGM2TDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,486.67 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injectors, with a completion deadline of January 26, 2026. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on January 2, 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen supplies a broad spectrum of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The Benlysta auto-injectors procured under this order support the Defense Health Agency and other government healthcare systems requiring this specialized biologic medication for systemic lupus erythematosus treatment.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 1/1/26 |